Skip to main content
GMRS
NYSE Life Sciences

Q3 Net Income Jumps 82% to $135.6M as GMR Lifts Full-Year Outlook

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.27
Mkt Cap
$608.825M
52W Low
$8.995
52W High
$15.98
52W Position info
25% above low
Off High info
29% below high
Rel. Volume info
3.1× avg
Market data snapshot near publication time

GMRS sits 25% above its 52-week low of $8.995 on elevated volume (3.1× avg).

Summary

GMR posted Q3 net revenue of $1,595.6 million, up 5.9% year over year, and net income of $135.6 million, up 81.7% from $74.6 million a year ago. Adjusted EBITDA rose 4.2% to $356.6 million, a much narrower gain than the net income jump, so the earnings beat is partly below-the-line: interest expense fell to $68.1 million from $107.2 million after the September term loan repricing and $200 million prepayment. That repricing, disclosed in the September 8-K, is now showing up in the numbers. The company updated full-year 2026 guidance to net revenue of $5,900-$6,050 million and Adjusted EBITDA of $1,135-$1,195 million. Liquidity stood at roughly $999.3 million, with $298.0 million of cash. This is the first quarterly report since the May IPO, and it lands after a cluster of insider sales in mid-September, including the CFO and President/COO each selling over $3 million of stock. The 8:00 a.m. ET call on November 10 will be the first chance for management to explain the payor-mix shift and weather drag on flight activity.

At the time of this announcement, GMRS was trading at $11.27 on NYSE in the Life Sciences sector, with a market capitalization of approximately $608.8M. The 52-week trading range was $9.00 to $15.98. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

GMRS - Latest Insights

GMRS
Sep 15, 2026, 6:06 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $13.26
Real-time Price: $11.28 info
Change: -$1.98 (-15%) info
Market Cap: $608.825M info
GMRS
Sep 15, 2026, 6:05 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $13.26
Real-time Price: $11.28 info
Change: -$1.98 (-15%) info
Market Cap: $608.825M info
GMRS
Sep 14, 2026, 9:09 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $13.26
Real-time Price: $11.28 info
Change: -$1.98 (-15%) info
Market Cap: $608.825M info
GMRS
Sep 11, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.78
Real-time Price: $11.28 info
Change: -$1.50 (-12%) info
Market Cap: $608.825M info
GMRS
Sep 11, 2026, 5:10 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $12.78
Real-time Price: $11.28 info
Change: -$1.50 (-12%) info
Market Cap: $608.825M info